Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
In this multicentric real-world observational retrospective study, we evaluated the efficacy and safety of dupilumab for atopic dermatitis in children <6 years of age who underwent a minimum of 16 weeks of therapy. The analysis focused on EASI (Eczema Area and Severity Index), CDLQI (Children’s Derm...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2025-12-01
|
| Serie: | Journal of Dermatological Treatment |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2460578 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|